Tangram Therapeutics Plc is a specialized research and development company focused on accelerating the development of novel genetic medicines. Established in 2001, the company operates within the broader field of research and experimental development, targeting unique therapeutic approaches. Tangram’s core competency lies in the integration of computational drug discovery, RNA interference (RNAi) technologies, and a distinct emphasis on unconventional thinking. The company’s strategic focus is on identifying and validating novel targets for genetic disease treatment. They employ a multidisciplinary team of scientists and engineers dedicated to innovative research across multiple disciplines. Currently, Tangram Therapeutics is active and operates within the SIC codes -72190: Other research and experimental development. The company’s international presence is currently limited, primarily operating within the European market. As a Skilled Worker visa holder, Tangram Therapeutics prioritizes a dynamic and collaborative work environment, fostering a culture of intellectual curiosity and problem-solving. The company’s key industry focus is the advancement of genetic medicine through novel therapeutic strategies.

Tangram Therapeutics Plc is a specialized research and development company focused on accelerating the development of novel genetic medicines. Established in 2001, the company operates within the broader field of research and experimental development, targeting unique therapeutic approaches. Tangram’s core competency lies in the integration of computational drug discovery, RNA interference (RNAi) technologies, and a distinct emphasis on unconventional thinking. The company’s strategic focus is on identifying and validating novel targets for genetic disease treatment. They employ a multidisciplinary team of scientists and engineers dedicated to innovative research across multiple disciplines. Currently, Tangram Therapeutics is active and operates within the SIC codes -72190: Other research and experimental development. The company’s international presence is currently limited, primarily operating within the European market. As a Skilled Worker visa holder, Tangram Therapeutics prioritizes a dynamic and collaborative work environment, fostering a culture of intellectual curiosity and problem-solving. The company’s key industry focus is the advancement of genetic medicine through novel therapeutic strategies.